West Family Investments Inc. Purchases 466 Shares of CME Group Inc. (NASDAQ:CME)

West Family Investments Inc. raised its position in shares of CME Group Inc. (NASDAQ:CME) by 31.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,970 shares of the financial services provider’s stock after acquiring an additional 466 shares during the quarter. West Family Investments Inc.’s holdings in CME Group were worth $435,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Y.D. More Investments Ltd acquired a new stake in CME Group during the second quarter worth approximately $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in shares of CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares in the last quarter. McClarren Financial Advisors Inc. grew its position in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the period. Asset Dedication LLC increased its stake in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares in the last quarter. Finally, New Covenant Trust Company N.A. acquired a new position in shares of CME Group during the 1st quarter valued at $82,000. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

CME stock opened at $229.66 on Wednesday. The business has a 50 day moving average of $223.02 and a 200-day moving average of $210.69. The firm has a market cap of $82.76 billion, a PE ratio of 24.15, a P/E/G ratio of 5.20 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.74. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the firm posted $2.25 earnings per share. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. As a group, sell-side analysts expect that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.00%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is 48.37%.

Analyst Upgrades and Downgrades

CME has been the subject of several research analyst reports. Piper Sandler lifted their price target on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Barclays raised their price objective on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Citigroup upped their target price on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Bank of America lifted their price target on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Finally, Oppenheimer upped their price objective on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $224.47.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock worth $3,441,063 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.